| Antiviral | EC50 ratio | Phenotype | Strain | Source | Marker | Assay | Reference |
|---|---|---|---|---|---|---|---|
| Filociclovir | <2.20 | No more than Low level resistance | Laboratory strain, Clinical Isolate | Recombinant | Details | Advances in the genotypic diagnosis of cytomegalovirus antiviral drug resistance. (Apr 2020) | |
| Maribavir | 1.30 | No resistance | Laboratory strain, Clinical Isolate | Recombinant | Details | Ganciclovir and maribavir cross-resistance revisited: Relative drug susceptibilities of canonical cytomegalovirus mutants. (Feb 2024) | |
| Ganciclovir | 7.50 | High level resistance | Laboratory strain, Clinical Isolate | Recombinant | Details | Ganciclovir and maribavir cross-resistance revisited: Relative drug susceptibilities of canonical cytomegalovirus mutants. (Feb 2024) |
| Mutant | Resistances |
|---|---|
| 595-603del |
Ganciclovir:
|
| L595del |
Ganciclovir:
|
| L595F |
Maribavir:
|
| L595F |
Ganciclovir:
|
| L595W |
Maribavir:
|
| L595W |
Ganciclovir:
|